Aua guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations

被引:677
作者
机构
关键词
D O I
10.1097/01.ju.0000078083.38675.79
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:530 / 547
页数:18
相关论文
共 100 条
[81]   TRANSURETHRAL INCISION OF PROSTATE (TUIP) - 646 CASES IN 15 YEARS - A CHRONOLOGICAL APPRAISAL [J].
ORANDI, A .
BRITISH JOURNAL OF UROLOGY, 1985, 57 (06) :703-707
[82]  
PARIKH AM, 1995, EUR UROL, V27, P1
[83]   Prostate specific antigen: A decade of discovery - What we have learned and where we are going [J].
Polascik, TJ ;
Oesterling, JE ;
Partin, AW .
JOURNAL OF UROLOGY, 1999, 162 (02) :293-306
[84]   TRANSURETHRAL RESECTION VERSUS INCISION OF THE PROSTATE - A RANDOMIZED, PROSPECTIVE-STUDY [J].
RIEHMANN, M ;
KNES, JM ;
HEISEY, D ;
MADSEN, PO ;
BRUSKEWITZ, RC .
UROLOGY, 1995, 45 (05) :768-775
[85]   NATURAL-HISTORY OF PROSTATISM - WORRY AND EMBARRASSMENT FROM URINARY SYMPTOMS AND HEALTH CARE-SEEKING BEHAVIOR [J].
ROBERTS, RO ;
RHODES, T ;
PANSER, LA ;
GIRMAN, CJ ;
CHUTE, CG ;
OESTERLING, JE ;
LIEBER, MM ;
JACOBSEN, SJ .
UROLOGY, 1994, 43 (05) :621-628
[86]   Serum prostate-specific antigen and prostate volume predict long-term chances in symptoms and flow rate: Results of a four-year, randomized trial comparing finasteride versus placebo [J].
Roehrborn, CG ;
Boyle, P ;
Bergner, D ;
Gray, T ;
Gittelman, M ;
Shown, T ;
Melman, A ;
Bracken, RB ;
White, RD ;
Taylor, A ;
Wang, D ;
Waldstreicher, J .
UROLOGY, 1999, 54 (04) :662-669
[87]   Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia [J].
Roehrborn, CG ;
McConnell, J ;
Bonilla, J ;
Rosenblatt, S ;
Hudson, PB ;
Malek, GH ;
Schellhammer, PF ;
Bruskewitz, R ;
Matsumoto, AM ;
Harrison, LH ;
Fuselier, HA ;
Walsh, P ;
Roy, J ;
Andriole, G ;
Resnick, M ;
Waldstreicher, J .
JOURNAL OF UROLOGY, 2000, 163 (01) :13-20
[88]   Correlation between prostate size estimated by digital rectal examination and measured by transrectal ultrasound [J].
Roehrborn, CG ;
Girman, CJ ;
Rhodes, T ;
Hanson, KA ;
Collins, GN ;
Sech, SM ;
Jacobsen, SJ ;
Garraway, WM ;
Lieber, MM .
UROLOGY, 1997, 49 (04) :548-557
[89]   Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia [J].
Roehrborn, CG ;
McConnell, JD ;
Lieber, M ;
Kaplan, S ;
Geller, J ;
Malek, GH ;
Castellanos, R ;
Coffield, S ;
Saltzman, B ;
Resnick, M ;
Cook, TJ ;
Waldstreicher, J .
UROLOGY, 1999, 53 (03) :473-480
[90]   Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia [J].
Roehrborn, CG ;
Boyle, P ;
Nickel, JC ;
Hoefner, K ;
Andriole, G .
UROLOGY, 2002, 60 (03) :434-441